Skip to content

CorMedix CRMD Stock Issued During Period Value In Connection With The Exercise Of Prefunded Warrants

Stock Issued During Period Value In Connection With The Exercise Of Prefunded Warrants at other companies

Quantum Computing Inc. logo
Quantum Computing Inc.QUBT
$12K
DJT
Trump Media & Technology GroupDJT
$94.1K-57.5%
Tidewater logo
TidewaterTDW
$1K-100.0%
HTF
Heartflow, Inc. Common StockHTFL
$16.18M
AvePoint, Inc. logo
AvePoint, Inc.AVPT
$0-100%
ADMA Biologics logo
ADMA BiologicsADMA
-$1K

Other financials

Income statement

See full
Revenue$127.4M+226%
Gross profit$115.4M+207%
Operating income$63.7M+216%
Net income$38.6M+87.0%
EPS (diluted)$0.43+43.3%

Balance sheet

See full
Cash & equivalents$179.1M+170%
Total debt$4.3M+729%
Total equity$437.0M+280%
Total assets$815.6M+445%

Cash flow

See full
Operating cash flow$42.4M+115%
CapEx$729.0K+7,190%
Free cash flow$41.7M+111%

Valuation

See full
Market cap$605.65M-34.4%
P/E3.4×
P/S1.5×-9.6×

Profitability

See full
Gross margin91.9%-3.5pp
Operating margin48.4%
Net margin45.2%
FCF margin48.7%+38.8pp

Returns & leverage

See full
Return on equity65.6%
Debt / equity0.0×
Current ratio-1.2×

Where this comes from

Reported directly by CorMedix in its filing.

Tagged under the XBRL concept crmd:StockIssuedDuringPeriodValueInConnectionWithTheExerciseOfPrefundedWarrants.

The official record: CorMedix’s 10-K, filed March 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about CorMedix's stock issued during period value in connection with the exercise of prefunded warrants.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CorMedix's stock issued during period value in connection with the exercise of prefunded warrants?
CorMedix (CRMD) reported stock issued during period value in connection with the exercise of prefunded warrants of $750 in Q4 2024.
What does stock issued during period value in connection with the exercise of prefunded warrants mean?
This metric captures the value of common stock issued upon the exercise of prefunded warrants. It indicates the conversion of derivative instruments into equity, often used as a mechanism to raise capital while managing share count limitations.